[Edaily Reporter Park Sun-Yeop ] Icure Pharmaceutical Incorporation(175250)announced on the 26th that it has withdrawn the application for permission to convene a shareholders’ meeting filed with the Seoul Central District Court by IK Partners Co., Ltd. and 75 others.
This case relates to the “Filing of Lawsuits and Applications” announced on March 9, in which the petitioners had sought permission from Icure Pharmaceutical Incorporation to convene a shareholders’ meeting.
According to the company, the petitioners’ legal representative submitted a motion to withdraw the application to the competent court on the 16th. Icure Pharmaceutical Incorporation confirmed the withdrawal on the same day.
Consequently, the legal proceedings surrounding the authorization to convene a shareholders’ meeting have concluded with the applicants’ withdrawal of the application.
This case relates to the “Filing of Lawsuits and Applications” announced on March 9, in which the petitioners had sought permission from Icure Pharmaceutical Incorporation to convene a shareholders’ meeting.
According to the company, the petitioners’ legal representative submitted a motion to withdraw the application to the competent court on the 16th. Icure Pharmaceutical Incorporation confirmed the withdrawal on the same day.
Consequently, the legal proceedings surrounding the authorization to convene a shareholders’ meeting have concluded with the applicants’ withdrawal of the application.
